nivolumab
bms
['nadim', 'nivo', '8501', 'nadimii']
#asco22 oral abstract session! abs#8501 dr. provencio-pulla presents #pcr analysis from #nadimii trial of #nivo+ chemo in iiia disease pcr 36% v 6.8% with chemo-io pcr pts had pd-l1 tps, pcr with tps aes 24% v 10% #adascovisabs 
Fellow @MayoHemeOnc | @UConnIM| @UTexasSPH| @MDAndersonNews|@COVID19nCCC| #SoMeEditor @JCOCCI_ASCO| Co-Host @HemOncFellows https://t.co/dsiuV460lQ, Views my own